血流导向支架治疗急性破裂颅内动脉瘤:40例连续病例的单中心经验
单中心回顾性分析2011至2024年40例急性破裂颅内动脉瘤患者,在出血后20天内单独或联合弹簧圈置入血流导向支架。末次随访mRS 0-2分者占75%,总体死亡率13%,随访影像完全闭塞率97%,手术相关并发症18%,其中动脉瘤再出血8%、支架内血栓8%。
要点
- 破裂后中位1.5天置入血流导向支架,随访完全闭塞率达97%。
- 末次随访mRS 0-2分者占75%,总体死亡率13%,手术相关死亡率5%。
- 手术相关并发症18%,再出血8%,支架内血栓8%(3例中包括仅有的2例单抗血小板治疗患者)。
核心结论
- 本组血流导向支架治疗破裂颅内动脉瘤获得良好临床结局和极佳动脉瘤闭塞率,并发症不可忽视,尤其是单抗血小板治疗相关的血栓风险;鉴于动脉瘤性蛛网膜下腔出血固有的高死亡风险,FDS仍是传统血管内治疗不合适动脉瘤的有用替代方案。
研究设计与样本
- 单中心回顾性研究,连续纳入2011至2024年40例急性破裂颅内动脉瘤患者,均在出血后20天内单独使用血流导向支架或同时联合弹簧圈治疗;主要结局为末次随访改良Rankin评分,次要结局为动脉瘤闭塞率和手术相关并发症。
诊断标准与关键数值
- 动脉瘤类型包括 blister-like 28例、梭形5例、夹层4例、囊状3例,73%位于前循环;置入血流导向支架距出血中位时间1.5天;末次随访mRS 0-2分占75%,总体死亡率13%,手术相关死亡率5%,随访影像完全闭塞率97%,手术相关并发症18%,动脉瘤再出血率8%,随访影像支架内血栓率8%(该3例患者包括仅有的2例接受单抗血小板治疗者)。
临床应用与阅片要点
- 作者认为,鉴于动脉瘤性蛛网膜下腔出血固有的高死亡风险,血流导向支架仍是传统血管内治疗不合适动脉瘤的有用替代方案;单抗血小板治疗与支架内血栓风险相关。
局限性
- 原文为单中心回顾性研究。
- 原文未报告样本量小、随访时间短等其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Certain subsets of acutely ruptured intracranial aneurysms (IAs) may require treatment with flow diverting stents (FDS); however, use of FDS in this context warrants antiplatelet therapy which may increase the risk of further haemorrhage. Here we present our single centre experience of 40 consecutive patients.
METHODS: We retrospectively reviewed our institutional databases for all patients between 2011 and 2024 with acutely ruptured IAs treated using FDS alone or with simultaneous coiling within 20 days of haemorrhage. Primary outcome was modified Rankin Score (mRS) at latest follow-up. Secondary outcomes were aneurysm occlusion rate and procedure-related complications.
RESULTS: Forty patients met the inclusion criteria: 22 females; mean age 44.7 years (range 18-66). These included 28 blister-like, 5 fusiform, 4 dissecting and 3 saccular aneurysms, with 73% in the anterior circulation. Median time to FDS insertion was 1.5 days from ictus. Favourable functional outcome (mRS 0-2) was observed in 75%. Overall mortality rate was 13% and procedure-related mortality rate was 5%. Complete aneurysm occlusion rate was 97% on follow-up imaging. Procedure-related complications occurred in 18%, with 8% aneurysm rebleed rate, and 8% in-stent thrombosis rate on follow-up imaging (this group of three patients includes the only two patients treated with single antiplatelet therapy (SAPT)).
CONCLUSION: Our series yielded favourable clinical outcomes and excellent aneurysm occlusion rate following FDS treatment of ruptured IAs. Complications are not negligible, especially the thrombotic risk associated with SAPT use. However, given the innate high mortality risk of aneurysmal subarachnoid haemorrhage, FDS remain a useful alternative for aneurysms unsuitable for traditional endovascular treatment options.
引用
- Liu JY, Caldwell J, Lee S, et al. Flow diverting stents in acutely ruptured intracranial aneurysms: a single centre experience of 40 consecutive cases. Neuroradiology. 2025. PMID: 40455107. doi:10.1007/s00234-025-03655-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。